Mr David R King

KANDO id: 36854

Bio

Joined Quaker BioVentures as Venture Partner in June 2008. Previously: CEO and co-founder of BioRexis Pharmaceutical Corporation (acquired by Pfizer), President of Delsys Pharmaceutical Corporation (acquired by Elan), CEO of Principia Pharmaceutical Corp. (acquired by Human Genome Sciences). Prior to becoming a successful serial entrepreneurial, David was a partner with Morgan, Lewis & Bockius LLP, where he founded and led the venture capital and emerging business practice. Diasome Pharmaceuticals (Chairman), Pennsylvania Biotechnology Association (PA Bio); University City Science Center. JD from Harvard Law School and undergraduate studies at the University of Pennsylvania

Education